$BCLI bottom Pr $3.87

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$BCLI bottom Pr $3.87


Website

NEW YORK and PETACH TIKVAH, Israel , Oct. 7, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the United States Food and Drug Administration (FDA) has designated NurOwn™ as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). NurOwn™ consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors, and is currently being studied in a randomized, double-blind, placebo-controlled phase 2 clinical trial in ALS patients.

"We are pleased that the FDA has granted Fast Track status for NurOwn™ as this will allow us greater and more frequent dialogue with the Agency as we continue the development of this ground-breaking cell therapy for the treatment of ALS," said Tony Fiorino , MD, PhD, Chief Executive Officer of BrainStorm. "We expect Fast Track designation, which recognizes the potential of NurOwn™ as to address an unmet medical need in ALS, to help speed and improve our development program."

The FDA's Fast Track program is designed to facilitate the development and expedite the review of drugs and biologics intended to treat serious conditions and demonstrate the potential to address unmet medical needs. Under the FDA Modernization Act of 1997, the Fast Track program provides for increased meetings with and written communications from the FDA, and allows for the submission of an NDA on a rolling basis. For more information, see http://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm .

About BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn™ technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University . NurOwn™ has been administered to over 30 patients with ALS in clinical trials conducted in Israel , and is currently being studied in a randomized, double-blind, placebo-controlled clinical trial in the United States.

Shares Outstanding: 15.16M
Float: 11.34M




Headlines

Tuesday, October 7, 2014
FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALSPR Newswire

Monday, October 6, 2014
BrainStorm Reports Last Patient Visit in Phase 2a ALS StudyPR Newswire

Friday, October 3, 2014
BRAINSTORM CELL THERAPEUTICS INC. FinancialsEDGAR Online Financials

Tuesday, September 30, 2014
BrainStorm Completes Uplisting to the NASDAQ Capital MarketMarketwired

Tuesday, September 16, 2014
BRAINSTORM CELL THERAPEUTICS INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, AmendmentsEDGAR Online
BrainStorm Announces Completion of Reverse Split of Common Stock, a Key Step for Uplisting on the NASDAQAccesswire
Tuesday, September 9, 2014
BrainStorm Provides Update on NASDAQ Uplisting ProcessMarketwired

Thursday, September 4, 2014
BrainStorm to Present at the Rodman and Renshaw 16th Annual Global Investment ConferenceAccesswire

Wednesday, September 3, 2014
BrainStorm Granted European Patent Covering its Stem Cells for the Treatment of CNS DiseasesAccesswire

Monday, August 18, 2014
FDA Clears Mayo Clinic for Manufacture of NurOwn and Participation in BrainStorm’s Phase 2 ALS TrialAccesswire

Wednesday, August 13, 2014
BCLI: Brainstorm Moves Into Phase 2 ALS TrialZacks Small Cap Research

Wednesday, July 30, 2014
Coverage initiated on Brainstorm Cell Therapeutics by Maxim GroupBriefing.com

Monday, July 28, 2014
BrainStorm Receives Notice of Allowance on US PatentAccesswire

Tuesday, July 15, 2014
BrainStorm Announces that University of Massachusetts Memorial Medical Center to Begin Enrolling Patients in Phase 2 ALS Clinical TrialAccesswire

Friday, July 11, 2014
BrainStorm Announces Publication of Preclinical Multidose Study of NurOwnMarketwired

Friday, June 27, 2014
BrainStorm Cell, Octane construct bioreactor prototype for NurOwntheflyonthewall.com
BrainStorm and Octane Successfully Construct a Bioreactor Prototype for Industrial-Scale Manufacturing or NurOwn Stem CellsMarketwired

Tuesday, June 24, 2014
Brainstorm Cell Therapeutics, Inc.: A Small Biotech With Big Plans And Huge Potentialat Seeking Alpha

Friday, June 13, 2014
BrainStorm Cell Therapeutics Raises $10.5 Million in Private Placement FinancingMarketwired

Thursday, June 12, 2014
BrainStorm Tackles Neurodegenerative Diseases With Novel Cell Therapyat Seeking Alpha



BrainStorm Cell Therapeutics Inc. (BCLI) Stock Research Links

BCLI Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chattanooga: A New Epicenter for Quantum Computing

Updated Category News Views 3

Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...

Continue Reading
Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 5

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
AI Ambassadors Rethink Arbitration's Future

Updated Category News Views 5

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Continue Reading
GenAI Boosts Grades and Tech Savvy for Online Learners

Updated Category News Views 3

What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...

Continue Reading
DAHON's Tech: Crafting Folders That Ride Like Road Bikes

Updated Category News Views 4

The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...

Continue Reading
Crimson Coward's Cheez Nugs Shake Up Fast-Casual Scene

Updated Category News Views 7

New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...

Continue Reading
Celebrate National Service Dog Month with Canine Companions

Updated Category News Views 5

A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
Invictus Pharmacy Secures LegitScript Certification Status

Updated Category News Views 2

A New Chapter for Invictus Pharmacy In a world tangled up in red tape, Invictus Pharmacy somehow managed to cut a clear path by earning the LegitScript Healthcare Merchant Certification. Now, it seems like they've joined the ranks of the big players, including the likes of Amazon Pharmacy. It’s not just a shiny badge on their website, folks. It’s better access to...

Continue Reading
Ensuring Your Radon Mitigation System Stays Effective

Updated Category News Views 2

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Continue Reading

Top 5 Most Recently Viewed Articles

Fangzhou Inc. Celebrated as a Leader in AI Healthcare Innovation

Updated Category News Views 254

Fangzhou Inc. Recognized for AI Innovations in Healthcare Fangzhou Inc. (06086.HK) stands out in the realm of Internet healthcare solutions, having recently earned accolades on the prestigious Guangzhou Artificial Intelligence Innovation Development List. The company was honored as the "Most Promising Enterprise" for the year, while its innovative H2H Smart Healthcare...

Continue Reading
Nutex Health Securities Fraud: What Investors Need to Know

Updated Category News Views 126

Nutex Health Inc. Securities Fraud Overview Nutex Health Inc. has found itself at the center of a securities fraud lawsuit that offers a vital opportunity for investors to seek justice. This development has significant implications for shareholders who may have been misled regarding the company's financial standing and operational integrity. Details on the Class Period...

Continue Reading
New Agreement Ensures Stability for East and Gulf Coast Ports

Updated Category News Views 225

New Agreement Ensures Stability for Dockworkers The recent negotiations between dockworkers and their employer groups have culminated in a pivotal agreement that promises stability for operations along the East and Gulf Coasts. With a tentative deal reached between the union representing the dockworkers and the United States Maritime Alliance (USMX), the fear of a major...

Continue Reading
Moldova Welcomes Global Vine and Wine Experts in 2025

Updated Category News Views 428

Moldova to Host the 46th World Congress of Vine & Wine The 46th World Congress of Vine and Wine is set to take place in Moldova, a nation rich with wine culture and heritage, from June 16 to 20, 2025. This event, coinciding with the OIV's 23rd General Assembly, marks a significant occasion for the wine industry of Moldova as it embraces a path toward sustainable...

Continue Reading
European DataWarehouse Launches Groundbreaking Data Access Solution

Updated Category News Views 136

European DataWarehouse Launches Innovative Platform EDVANCE European DataWarehouse (EDW) has introduced its latest innovation, the AI-enabled data access platform named EDVANCE. This cutting-edge tool aims to streamline how users interact with public and private securitisation data. Streamlined Access to Securitisation Data The newly developed EDVANCE platform simplifies...

Continue Reading